|
SMNDC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.022400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.128800E-01 |
| Normal-vs-Stage2 |
8.447600E-01 |
| Normal-vs-Stage3 |
5.614500E-02 |
| Normal-vs-Stage4 |
1.991770E-01 |
| Stage1-vs-Stage2 |
6.787600E-01 |
| Stage1-vs-Stage3 |
1.086130E-02 |
| Stage1-vs-Stage4 |
5.934100E-02 |
| Stage2-vs-Stage3 |
3.070200E-01 |
| Stage2-vs-Stage4 |
5.627800E-01 |
| Stage3-vs-Stage4 |
4.488200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.385200E-01 |
| Normal-vs-AfricanAmerican |
5.424200E-01 |
| Normal-vs-Asian |
1.035790E-01 |
| Caucasian-vs-AfricanAmerican |
9.083600E-01 |
| Caucasian-vs-Asian |
1.422580E-01 |
| AfricanAmerican-vs-Asian |
1.245050E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.778400E-01 |
| Normal-vs-Female |
8.670600E-01 |
| Male-vs-Female |
1.567000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.600000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.473400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.259600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.288000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.311400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.374200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.625400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.000200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.893630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.861200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.548300E-02 |
| Normal-vs-Grade 2 |
3.043600E-01 |
| Normal-vs-Grade 3 |
5.532400E-02 |
| Normal-vs-Grade 4 |
1.806350E-02 |
| Grade 1-vs-Grade 2 |
1.774180E-01 |
| Grade 1-vs-Grade 3 |
4.658300E-03 |
| Grade 1-vs-Grade 4 |
2.900900E-03 |
| Grade 2-vs-Grade 3 |
8.612400E-04 |
| Grade 2-vs-Grade 4 |
6.595100E-04 |
| Grade 3-vs-Grade 4 |
3.341400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.891700E-02 |
| Normal-vs-ccB subtype |
2.915900E-02 |
| ccA subtype-vs-ccB subtype |
4.11639999999824E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.270600E-01 |
| Normal-vs-N1 |
4.612000E-01 |
| N0-vs-N1 |
7.140800E-01 |
|
|
